Federal contract award

75F40124F19001

THE OBJECTIVE OF THIS BPA IS TO PROCURE TECHNICAL AND MANAGEMENT CONSULTING SERVICES TO COMPREHENSIVELY SUPPORT THE PLANNING FOR AND IMPROVEMENTS IN BUSINESS OPERATIONS ACROSS THE FDA ENTERPRISE.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541611 — Administrative Management and General Management Consulting Services
PSCR799 — Other Management Support Services
Parent award / vehicle75F40124A00001
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$176.4K
Current contract value$176.4K
Potential contract value / ceiling$176.4K
Start dateJul 11, 2024
Current end dateApr 8, 2025
Potential end dateJul 31, 2026
Latest award activityAug 5, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 5, 2026P00004$-0THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS AND CLOSE OUT THE CONTRACT.
Dec 9, 2025P00003$-175.9KTERMINATION SETTLEMENT FOR THE FULL TERMINATION FOR THE CONVENIENCE OF THE GOVERNMENT UNDER P00002
Apr 8, 2025P00002$0EOI:: GSA WASTEFUL SPENDING ::EOI FULL TERMINATION FOR CONVENIENCE
Nov 7, 2024P00001$0THE OBJECTIVE OF THIS BPA IS TO PROCURE TECHNICAL AND MANAGEMENT CONSULTING SERVICES TO COMPREHENSIVELY SUPPORT THE PLANNING FOR AND IMPROVEMENTS IN BUSINESS OPERATIONS ACROSS THE FDA ENTERPRISE.
Jul 11, 20240$352.2KTHE OBJECTIVE OF THIS BPA IS TO PROCURE TECHNICAL AND MANAGEMENT CONSULTING SERVICES TO COMPREHENSIVELY SUPPORT THE PLANNING FOR AND IMPROVEMENTS IN BUSINESS OPERATIONS ACROSS THE FDA ENTERPRISE.

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.